Thank you, Shire, for supporting AWE's mission to create more diversity in corporate America. Together we can increase the number of women in corporate leadership and on boards to improve the global economy.
Newly combined with Baxalta, Shire is now the leading global biotechnology company focused on serving people affected by rare diseases and other highly specialized conditions. These diseases are often misunderstood, under-diagnosed, and potentially life-threatening. Their 22,000 employees come to work every day with a common purpose: to develop and deliver breakthrough therapies that enable people with life-altering conditions to live their lives to the fullest.